Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 132 entries
View as:

T-regulatory Cells in ALS

Phase: N/A Priority: Normal
NCT ID: NCT04055623 Org: User:
Start: 08/07/19 End: 08/31/22 Due: 08/31/23

Ciprofloxacin for Prevention of BK Infection

Phase: N/A Priority: Normal
NCT ID: NCT01789203 Org: User:
Start: 01/31/13 End: 10/31/17 Due: 10/31/18

Low-intensity Shockwave Therapy for Post-radical Prostatectomy Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT06219785 Org: User:
Start: 01/10/24 End: 10/01/24 Due: 10/01/25

The Use of CoSeal (Sealant Agent) in Patients During Left Ventricular Assist Device Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01605019 Org: User:
Start: 06/30/12 End: 03/31/14 Due: 03/31/15

Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00440973 Org: User:
Start: 10/31/06 End: 11/30/07 Due: 11/30/08

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03541928 Org: User:
Start: 08/02/18 End: 07/31/23 Due: 07/31/24

Opioid Use After Thyroid and Parathyroid Surgeries

Phase: N/A Priority: Normal
NCT ID: NCT04955444 Org: User:
Start: 06/14/21 End: 12/31/21 Due: 12/31/22

Improving Adherence to Rabies PEP Guideline Recommendations

Phase: N/A Priority: Normal
NCT ID: NCT04213950 Org: User:
Start: 12/29/19 End: 12/23/20 Due: 12/23/21

Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT00448097 Org: User:
Start: 02/28/07 End: 08/31/08 Due: 08/31/09

Prospective Cohort of Transitional Urology Patients

Phase: N/A Priority: Normal
NCT ID: NCT03061084 Org: User:
Start: 08/27/15 End: 12/31/24 Due: 12/31/25

Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02176720 Org: User:
Start: 05/31/14 End: 03/31/16 Due: 03/31/17

Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06833866 Org: User:
Start: 12/04/24 End: 12/01/25 Due: 12/01/26

Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant

Phase: N/A Priority: Normal
NCT ID: NCT04665310 Org: User:
Start: 09/01/18 End: 10/31/25 Due: 10/31/26

Venous Ethanol for Ventricular Tachycardia

Phase: N/A Priority: Normal
NCT ID: NCT05511246 Org: User:
Start: 04/12/23 End: 12/12/28 Due: 12/12/29

IL-2 Plus Abatacept in FTD

Phase: N/A Priority: Normal
NCT ID: NCT06395038 Org: User:
Start: 05/06/24 End: 04/30/26 Due: 04/30/27

Prehabilitation for Kidney Transplant Candidates

Phase: N/A Priority: Normal
NCT ID: NCT06886256 Org: User:
Start: 03/26/25 End: 09/30/25 Due: 09/30/26

Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00521274 Org: User:
Start: 08/31/07 End: 08/31/08 Due: 08/31/09

Ocrelizumab for Psychosis by Autoimmunity

Phase: N/A Priority: Normal
NCT ID: NCT03971487 Org: User:
Start: 10/01/19 End: 10/30/25 Due: 10/30/26

Effect of BFR Rehab After Achilles Tendon Rupture

Phase: N/A Priority: Normal
NCT ID: NCT06254794 Org: User:
Start: 11/13/18 End: 12/31/28 Due: 12/31/29

Phase II Clinical Trial of Interleukin-2 in AD

Phase: N/A Priority: Normal
NCT ID: NCT06096090 Org: User:
Start: 01/01/22 End: 12/30/25 Due: 12/30/26

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

Phase: N/A Priority: Normal
NCT ID: NCT05660083 Org: User:
Start: 01/12/23 End: 12/02/28 Due: 12/02/29

Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05582200 Org: User:
Start: 01/20/23 End: 10/31/25 Due: 10/31/26

Durvalumab with Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03820141 Org: User:
Start: 03/03/20 End: 12/31/25 Due: 12/31/26

Mesenchymal Stromal Cells in Living Donor Kidney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03478215 Org: User:
Start: 12/31/16 End: 12/31/26 Due: 12/31/27

Safety of Riluzole in Patients With Acute Spinal Cord Injury

Phase: N/A Priority: Normal
NCT ID: NCT00876889 Org: User:
Start: 04/30/10 End: 04/30/12 Due: 04/30/13